LumiThera Inc

LumiThera, Inc. is a Washington-based company with two employees. LumiThera develops and commercializes light-based innovations for diagnosing, monitoring, and treating blinding eye diseases. Their core products include the Valeda® Light Delivery System, which utilizes multiwavelength photobiomodulation (PBM) to treat dry age-related macular degeneration (AMD), and AdaptDx Pro®, a dark adaptation functional testing technology that helps detect and monitor AMD. LumiThera also offers Diopsys® ERG and VEP systems for analyzing visual and neuro-visual disorders. The company's Valeda® system is CE Marked in the European Union and available in select Latin American countries. AdaptDx Pro® is listed on the FDA’s Establishment Registration & Device Listing, while Diopsys® VEP has FDA clearance. Interested parties can learn more about LumiThera and its products at lumithera.com.